Implanet Announces 2020 Revenue of €6 Million
Implanet Announces 2020 Revenue of €6 Million Fourth quarter JAZZ sales up 9% compared with the fourth quarter of 2019, with 34% growth in the United States Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral and knee-surgery implants, today announced its provisional unaudited fourth-quarter revenue, annual revenue and cash position at December 31, 2020. Ludovic Lastennet, Implanet's Chief Executive Officer, commented: " Although down versus prior year, our revenue ...